CSS
ARCT icon

Cubist Systematic Strategies’s Arcturus Therapeutics ARCT Stock Holding History

Cubist Systematic Strategies’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,357
Closed -$694K – 2994
2025
Q2 		$694K Buy
+53,357
New +$631K ﹤0.01% 2115
2024
Q4 		– Sell
-23,436
Closed -$544K – 2953
2024
Q3 		$544K Buy
+23,436
New +$501K ﹤0.01% 2170
2024
Q2 		– Sell
-92
Closed -$3.11K – 2947
2024
Q1 		$3.11K Sell
92
-12,094
-99% -$429K ﹤0.01% 3563
2023
Q4 		$384K Buy
+12,186
New +$290K ﹤0.01% 2664
2023
Q3 		– Sell
-36,817
Closed -$1.06M – 3314
2023
Q2 		$1.06M Sell
36,817
-87,565
-70% -$2.38M 0.01% 1919
2023
Q1 		$2.98M Buy
124,382
+69,517
+127% +$1.25M 0.02% 1349
2022
Q4 		$931K Buy
+54,865
New +$957K 0.01% 2515
2022
Q3 		– Sell
-39,749
Closed -$626K – 4406
2022
Q2 		$626K Buy
39,749
+34,514
+659% +$677K ﹤0.01% 2871
2022
Q1 		$141K Buy
+5,235
New +$134K ﹤0.01% 3146
2021
Q4 		– Sell
-15,684
Closed -$749K – 3451
2021
Q3 		$749K Buy
15,684
+6,646
+74% +$298K 0.01% 1741
2021
Q2 		$306K Sell
9,038
-20,042
-69% -$678K ﹤0.01% 2316
2021
Q1 		$1.2M Buy
+29,080
New +$1.73M 0.02% 1408
2020
Q4 		– Sell
-9,962
Closed -$427K – 2548
2020
Q3 		$427K Sell
9,962
-21,638
-68% -$1.07M 0.01% 1833
2020
Q2 		$1.48M Buy
+31,600
New +$1.09M 0.03% 965

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Cubist Systematic Strategies's ARCT Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 53,357 shares — an estimated $694K sold.

Cubist Systematic Strategies first reported a position in ARCT in Q2 2020 and held it in 14 quarters. The position peaked at $2.98M in Q1 2023. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 53,357 Arcturus Therapeutics shares in Q3 2025, an estimated $694K.
  • Cubist Systematic Strategies first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 14 quarters.
  • Cubist Systematic Strategies's Arcturus Therapeutics position peaked at $2.98M in Q1 2023.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.